Flowbone Raises CHF 2.1 Million to Bring Nanomedicine-based Bone Repair to the Market

Founded by Dr. Ulrike Kettenberger, Prof Dominique Pioletti, and Dr. Rgis Gauderon and incorporated in July 2020, flowbone leverages regenerative nanomedicine to transform the care of millions of patients with bone diseases and disorders, such as osteoporosis. Currently, flowbone is transferring its technology to the first commercial product for bone repair. The company will target…

Details

TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia

Tigecycline is regarded as the last line of defense to combat multidrug-resistant Klebsiella pneumoniae. However, increased use has led to increased drug resistance and treatment failures. Here we design D-alpha tocopheryl polyethylene glycol nanorods by succinate and S-thanatine peptide functionalized based on calcium phosphate nanoparticles for tigecycline delivery and treatment pneumonia caused by tigecycline-resistant pneumoniae.…

Details

Polymeric micelles in TKIs’ delivery for cancer treatment

B. Dashtipoura,b, M. Dehghanib, S. Honarmandb, N. Nikzadb, M. Dastjerdib, A. Akbaria, S. Akbaria,b aGreenNanoTech Kft, Király Utca 80, Budapest, 1068, Hungary bNanoSciTec GmbH, Hermann Weinhauser str. 67, Munich, 81867, Germany Abstract Polymeric micelles (PMs), one of the most popular nanotechnology platforms for the delivery of various kinds of chemotherapeutics, are aggregated colloids formed through…

Details